Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Repower Asia Indonesia Tbk. (REAL) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Repower Asia Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Repower Asia Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Repower Asia Indonesia Tbk. trades at Rp53 (market cap 351.58B, 40.49M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Repower Asia Indonesia Tbk. are close in size by market cap, and Repower Asia Indonesia Tbk. is more actively traded (40.49M versus 41.7K). Which is the better fit depends on your goals.

DGNSREAL
Market Cap
316.25B351.58B
Volume
41.7K40.49M
Lot
417404.91K
Turnover
9.66M2.13B
Average Price
231.6552.49
Value
9.66M2.13B
Indicative Equilibrium Price
23053
Indicative Equilibrium Volume
2.4K18.42K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
REAL
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Repower Asia Indonesia Tbk.

PT Repower Asia Indonesia Tbk (the Company) was established based on Notarial Deed No. 04 of Titik Krisna Murti Wikaningsih, S.H., M.KN., dated March 13, 2011, a Notary in Bekasi.

Read more on REAL